The Venture Codex Logo

The Venture Codex

Avego Bioscience Capital

1055B Powers Place, Alpharetta, GA, 30009, UNITED STATES

Overview

Investment firm focused on bioscience.

Deals · 12mo

5

Links

WebsiteLinkedIn

Stage focus

Multi-stage

Geographic focus

Canada
Switzerland
The Netherlands
United Kingdom
...

Sector focus

—

Investment portfolio

17rounds
NAMEDATESIZE
CellCentric
May 2026Participated
$220 MSeries D
Alveus Therapeutics
Mar 2026Participated
$197 MSeries A
Alveus Therapeutics
Jan 2026Participated
$160 MSeries A
EpiBiologics
Jan 2026Participated
$107 MSeries B
myTomorrows
Nov 2025Led
$29 MOther Equity
MapLight Therapeutics
Jul 2025Participated
$373 MSeries D
CellCentric
May 2025Participated
$120 MSeries C
PBS Biotech
Jan 2025Led
$17 MOther Equity
TRex Bio
Nov 2024Participated
$84 MSeries B
Alentis Therapeutics
Nov 2024Participated
$181 MSeries D
Evommune
Oct 2024Participated
$115 MSeries C
PBS Biotech
Jan 2023Led
$22 MOther Equity
CellCentric
May 2026Participated
$220 MSeries D
Alveus Therapeutics
Mar 2026Participated
$197 MSeries A
Alveus Therapeutics
Jan 2026Participated
$160 MSeries A
EpiBiologics
Jan 2026Participated
$107 MSeries B
myTomorrows
Nov 2025Led
$29 MOther Equity
MapLight Therapeutics
Jul 2025Participated
$373 MSeries D
CellCentric
May 2025Participated
$120 MSeries C
PBS Biotech
Jan 2025Led
$17 MOther Equity
TRex Bio
Nov 2024Participated
$84 MSeries B
Alentis Therapeutics
Nov 2024Participated
$181 MSeries D
Evommune
Oct 2024Participated
$115 MSeries C
PBS Biotech
Jan 2023Led
$22 MOther Equity
17
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Avego Bioscience Capital: 17 funding rounds are recorded in the selected participation categories.All available history.
Avego Bioscience Capital: 17 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A12
Series B03
Series C+07
Other Equity31

Monthly Deal Activity

Avego Bioscience Capital: 17 deals are recorded across 68 months.All available history.
Avego Bioscience Capital: 17 deals are recorded across 68 months. All available history
MonthDeals
Mar '211
Apr '210
May '210
Jun '210
Jul '211
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '221
Sep '220
Oct '220
Nov '221
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '242
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '251
Aug '250
Sep '250
Oct '250
Nov '251
Dec '250
Jan '262
Feb '260
Mar '261
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Avego Bioscience Capital: Health & Life Sciences is the largest displayed sector by deal count (17 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Avego Bioscience Capital: Health & Life Sciences is the largest displayed sector by deal count (17 deals). All available history
SectorDeals
Health & Life Sciences17
Manufacturing2
Space & Frontier Tech1

Deal Size Distribution

Avego Bioscience Capital: 17 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Avego Bioscience Capital: 17 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M2
$50M-$100M3
$100M-$250M9
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Avego Bioscience Capital: United States has the largest recorded deal count among the displayed regions (12 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Avego Bioscience Capital: United States has the largest recorded deal count among the displayed regions (12 deals). All available history
RegionDeals
United States12
Europe4
Canada1
Avego Bioscience Capital: 20 co-investors are shown, with RA Capital Management sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Avego Bioscience Capital: 20 co-investors are shown, with RA Capital Management sharing 5 recorded deals. All available history
Co-investorShared deals
RA Capital Management5
Andera Partners3
Forbion3
Johnson & Johnson Innovation3
Novo Holdings3
Sanofi Ventures3
5AM Ventures2
AbbVie Ventures2
Adage Capital Management2
BroadOak Capital Partners2
Delos Capital2
Google Ventures2
Jeito Capital2
Kurma Partners2
LifeSci Venture Partners2
Monashee Investment Management2
New Rhein Healthcare Investors2
Novartis2
Omega Funds2
Osage University Partners2

Investment Strategy

Avego Bioscience Capital: Led accounts for 24% and participating for 76% of round participation.All available history.
Avego Bioscience Capital: Led accounts for 24% and participating for 76% of round participation. All available history
CategoryDeals (count)Share (%)
Led424%
Participating1376%
Avego Bioscience Capital: Single-lead accounts for 75% and co-led for 25% of lead dynamics.All available history.
Avego Bioscience Capital: Single-lead accounts for 75% and co-led for 25% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead375%
Co-led125%

Team

Eric Pham

Managing Director

James Flexner
Vishal Kapoor